Cobalis Corp. Schedules Marketing Update Conference Call for Investors for Sept 14.

Share Article

Cobalis Corp. is pleased to announce that with our recent positive development of the PreHistin® distribution network and imminent marketing launch, we will be conducting our first series of investor conference calls on Sept 14.

Cobalis to hold investor conference call update Sept 14 at 10:15 PST. RSVP for details and dial-in info 949-260-0023.

Cobalis Corp. (Pink Sheets: CLSC.PK) Cobalis Corp. (http://www.cobalis.com) is pleased to announce that with our recent positive development of the PreHistin® distribution network and imminent marketing launch, we will be conducting our first series of investor conference calls.

Shareholders and investors must RSVP to participate in this conference call, which will be held on Tuesday, September 14, 2010 at 1:15pm PST (Pacific Standard Time). All shareholders can RSVP to participate in the conference call by contacting Cobalis at (949) 260-0023 between 9:00 am and 5:00 pm Pacific Time, Monday through Friday, to get the conference call dial-in number and passcode.

Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin® Allergy Defense Formula, The World's FIRST Pre-Histamine, is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin® is available without prescription for both long-term and daily use.

FORWARD LOOKING STATEMENTS
Cobalis Corp., expectation of results and other forward-looking statements contained in this email involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those expected are the following: business conditions and general economic conditions; competitive factors, such as pricing and marketing efforts; and the pace and success of product research and development. These and other factors may cause expectations to differ.

ABOUT COBALIS CORP—PREHISTIN®
Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin® Allergy Defense Formula, The World’s FIRST Pre-Histamine, is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin® is available without prescription for both long-term and daily use.

For PreHistin® product information and ordering please visit at http://www.PreHistin.com or call toll free 1-877-4POLLEN. For additional company information please visit the corporate website at http://www.Cobalis.com

Contact:
Cobalis Corp.
16795 Von Karman, Suite 200
Irvine, CA 92606
949-260-0023
Chas Radovich, President
Martin Marion, CEO
info(at)cobalis(dot)com
info(at)prehistin(dot)com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chas Radovich
Visit website